0000000016 00000 n payers and providers, can address the changing needs of society more effectively.“Pharma 2020: Marketing the future” is the third in this series of papers on the future of the pharmaceutical industry published byPricewaterhouseCoopers. (Getty/Kritchanut) A report out this week by PwC thinks biotech could be in for a good year for deals as it sees the momentum from 2019 growing, although don’t expect many mega-deals. Which path will you take?' Pharma 2020: Marketing the future - Which path will you take? Set preferences for tailored content suggestions across the site, Healthcare policy makers and payers are increasingly mandating what doctors can prescribe, The boundaries between different forms of healthcare are blurring, The markets of the developing world, where demand for medicines is likely to grow most rapidly over the next 13 years, are highly varied, Governments are beginning to focus on prevention rather than treatment, Recognise the interdependence of the payer, provider and pharmaceutical value chains, Invest in developing medicines the market wants to buy, Adopt a more flexible approach to pricing, Develop plans for marketing and selling specialist therapies, Manage multi-country launches and live licensing, Form a web of alliances to offer supporting services, Create cultures that are suitable for marketing specialist healthcare packages, Develop marketing and sales functions that are fit for the future and a knowledge based commercial organisation. Companies will need to demonstrate that their brand adds value to patients and they will have to offer a package of products and health services that the market not only wants and needs but is willing to pay a premium for. „ŒM\. Pharma 2020: Marketing the future – Which path will you take? 178 23 Subscribe for weekly pharma marketing insights. Pharma … ... to work more efficiently, make the sale and marketing expenditures more transparent, and reinforce the financial results. 2020. 178 0 obj <> endobj Listen to Steve Arlington discuss the key highlights from Pharma 2020. The Indian pharma industry is showing signs of healthy growth and is likely to be in the top 10 global markets by value by 2020. 0000011011 00000 n trailer the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. 0000008258 00000 n “Pharma 2020: Marketing the future” is the third in this series of papers on the future of the pharmaceutical industry published by PricewaterhouseCoopers. Washington, D.C.: PwC and the Urban Land Institute, 2019. The 3 rd Annual Future Pharma Marketing Summit is the only event of its kind in Canada, designed to help you overcome the unique challenges in pharmaceutical marketing. At PwC, we’re balancing business understanding with technology innovation and human insight, to help solve this important problem. Global Pharmaceutical and Life Sciences Assurance Leader, PwC Switzerland, Global Pharmaceutical and Life Sciences Tax Leader, PwC United Kingdom. Please see www.pwc.com/structure for further details. the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. 200 0 obj <>stream 0000006436 00000 n Finding the right tools can make you successful. Around the same time (September–October 2020), PwC conducted a larger online global survey that attracted 670 responses from businesses across the world. Total Value of the Pharmaceutical Sector Today over $5 Trillion 20 - Total revenue in the pharma sector around $1.1 trillion in 2017 23 - Total value of companies in sector over $5 trillion. For the first time ever, the marketing services units of Accenture, PwC, IBM, and Deloitte ranked just below WPP, Omnicom, Publicis Groupe, Interpublic, and Dentsu. Start adding content to your list by clicking on the star icon included in each card. Future Pharma brings together heads of brands and franchises, marketing, sales and digital executives from leading pharmaceutical companies in an interactive and energizing setting. 0000003178 00000 n Naturally, the pharma marketer has an important ongoing role to play. Pharma 2020… Marketing the future. The latest about the new Belgian government Discover which 4 key areas are impacted by government plans from a tax perspective. 0000001910 00000 n (Posted by pwc… The primary objective of the India-based study was to understand the awareness, adoption and impact of AI in the post COVID-19 landscape. Pharma 2020: Marketing the future - Which path will you take? by Ben Adams A new PwC report sees M&A for biotech to be in the middling $2 billion to $10 billion range. 0000004148 00000 n Pharma in 2020 New virtual reality technology may lead to the cost and length of clinical trials falling significantly by the year 2020 PWC's report, Pharma 2020: virtual R&D, says that the process of testing, researching and developing new drugs could be cut by two thirds and that success and approval rates could rise dramatically. This post will explore some of the key trends and themes from this year so far to gauge what 2021 will look like so that pharma marketing departments can begin to focus on a new landscape shaped by the events of 2020. 0000022903 00000 n %PDF-1.4 %âãÏÓ the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. To help us achieve this we have the PwC Professional; our global leadership development framework. Around the world, people are living longer. 0000014493 00000 n .¿\û¦‚õİP�úıˆØƈ5!ÁcR´áKˆ ]½Ø£ìiWÎ0SÀ¶R?3N ßÙøe§Üu ä”O,ş›¡6 #ç�<\~ úö;ÇB;`è.q‘°dÒp„„5˜4³ ÓĞØT(è ¥ˆHÊ`KËèh€qY; ¢Æ£ �’khD€yÂÆ`„v€• The pharmaceutical industry is experiencing major upheavals, as PwC US has noted in earlier papers in our Pharma 2020 series.Many companies have responded by focusing on discovering, developing and marketing medicines more efficiently; but to date they’ve invested less effort in reconfiguring their manufacturing and distribution operations. Technology is shaping the way we do business more than ever before. ... By 2020 the current role of the pharmaceutical industry’s sales and marketing workforce will be replaced by a new model as the industry shifts from a mass-market to a target-market approach to increase revenue. The publication outlines the changes we believe will best help pharmaceutical companies realise the potential the future holds to enhance the value they provide to shareholders and society alike. ;‡ˆÇÈÂp�E€,ãÀ¦dfë$0LàVbº| c‚Ríª‰ ‹%í¸÷T—«§ÿ�Ιc¾Œw8Ép)2¾s(¼ôæ »–b–ƒO÷C¦‡ ù ¼ Ì«T“ø—§™ 0000020361 00000 n [Webinar] Future of Biotech: How to speed up high-density cell banking processes using a single-use, closed system. By 2050, there will be two billion people that are 60 years or older globally. ]Â#A6<3ˬè¿nY-… 5 «%lÜ‚–n›áğ¨d;PP±dß“W¡j All rights reserved. Doing Business in the Netherlands 2020 is composed in collaboration with the NFIA (The Netherlands Foreign Investment Agency) and is intended to provide a broad understanding of the key aspects of doing business and investing in the Netherlands. We’re using the power of Intelligent Digital to see beyond the technology gender gap, to a world where women play an equal part in creating our future. Foreword Welcome to the CII Pharma Summit 2012. © 2017 - Sat Jan 16 07:36:02 UTC 2021 PwC. Pharma 2020: Taxing times ahead Which path will you take? By 2020, electronic medical records, e-prescribing and remote monitoring will give healthcare payers and providers in many countries access to extensive outcomes data. Visualizing the Future of the Pharma Market. ABOUT THE AUTHOR > Anthony Farino is U.S. Pharmaceutical and Life Sciences Advisory Services Leader at PricewaterhouseCoopers. Connect with hundreds of like-minded peers to discuss the latest innovations in digital pharma marketing. Discover PwC’s four cutting-edge digital tax and regulatory solutions for pharma & life sciences companies and how they can add value to your business, help you comply with new laws and stay up to date with upcoming changes. PwC and the Urban Land Institute: Emerging Trends in Real Estate® Asia Pacific 2020. This report highlights the fundamental dynamics the industry faces that are reshaping the pharmaceutical marketplace: In order to be successful, companies will need to stop the aggressive marketing focusing only on the product of the current model and: This paper explores how the industry's approach to sales and marketing will change as it moves towards providing products and service to improve the health of patients, whilst clearly demonstrating value for money. 0000003450 00000 n It discusses the key forces reshaping the pharmaceutical marketplace, including the growing power of healthcare payers, 0000004235 00000 n www.pwc.com/pharma2020 Pharma 2020: Supplying the future Which path will you take?Pharmaceutical… 0000001789 00000 n PwC M&A was engaged to run a structured investor process to find the best strategic partner for kfgn to support its further development into extended business offerings, capitalising on kfgn's already commenced digital services. 0000002364 00000 n In fact, according to the PwC report, titled, ‘Pharma 2020: Supplying the future. It gives us a single set of expectations across our lines, geographies and career paths, and provides transparency on the skills we need as individuals to be successful and progress in our careers, now and in the future. startxref From vision to decision. Publications in this series include: Pharmaceuticals Published in June 2007, this Pharmaceuticals and Life Sciences Published in February 2009, paper highlights a number of this paper discusses the key issues that will have a major forces reshaping the Pharma 2020: The vision bearing on the industry by Pharma 2020: Marketing the future pharmaceutical marketplace, Which path will you take? 0000000756 00000 n Meanwhile, the amount of seniors (65+ years old) in the U.S. will double to 100 million by 2060. Hear from GSK, AbbVie, Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, PAAB, Takeda, UHN and more! COVID-19 has increased the pressure on pharma companies, as social distancing and isolation measures mean that traditional face-to-face meetings between doctors and sales representatives or medical science liaisons (MSL) will be restricted for the foreseeable future. In order to drive profitable growth in the future, companies will have to rethink the way they do business today. Pharma 2020: Marketing the future - a PWC paper. * 2020. 0000011843 00000 n Explore more. Pharma 2020. The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. The share purchase agreement for kfgn was signed on 9 th June 2020 and the transaction was closed on 15 th June 2020. PwC’s Brexit podcast series How Brexit will affect your business and the actions you need to take. ISBN: 978-0-87420-442-1 Editorial Leadership Team ii Emerging Trends in Real Estate® Asia Pacific 2020 Communications, Asia Pacific The sixth paper in the Pharma 2020 series highlights how pharma companies will have to develop different supply chain models for different product types and patient segments and learn to use their supply chains as a means of market differentiation and source of economic value. In its report, “India Pharma 2020”, McKinsey & Company had projected for $55 billion, with the potential to achieve $70 billion. <]>> Excerpted from “Pharma 2020: Marketing the Future,” the third in a series of papers on the future of the pharmaceutical industry published by PricewaterhouseCoopers. The paper highlights some very strong facts related to the need for Pharma to change its marketing and sales functions in order to sustain future growth and performance. But it had also thrown in a caveat. 0000004349 00000 n PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. By 2020 the current role of the pharmaceutical industry’s sales and marketing workforce will be replaced by a new model as the industry shifts from a mass-market to a target-market approach to increase revenue. 0000003141 00000 n 0000010103 00000 n The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. - Based upon expected GDP growth, the pharma sector will likely triple in size by 2060 19 4. %%EOF At the J.P. Morgan Healthcare Conference last week in San Francisco, PwC's Greg Rotz outlined the challenges and opportunities for pharma marketers in specialty care. This report outlines in some detail what those changes in the business environment will be and provides pharma companies with indicators of organisational and operational structure that could influence their success and readiness to compete. 0000007330 00000 n Pharma 2020: Virtual R&D Pharmaceuticals and Life Sciences Pharma 2020: Marketing the future Which path will you take? 0000004461 00000 n change in the industry's remit has even more fundamental implications for supply chains. 0 0000009209 00000 n “Pharma 2020: Challenging business models” is the fourth paper in the Pharma 2020 series on the future of the pharmaceutical industry to be 0000005502 00000 n London, +44 20 7804 3744, jo.pisani@uk.pwc.com • Jo has overall responsibility for PwC Strategy’s pharmaceuticals teams and focuses on business strategy, valuations, portfolio management and commercial due diligence Simon Friend – Partner, Global Head of Health Industries, London, +44 20 7213 4875, simon.friend@uk.pwc.com ñÀÂaP´¼{�AÀÉÅ©}Í"œLêç˜Ø4�p4)aµŞy<2�Â[¸XN.NofwéUdR¿Ğ¤S²Â Ñ¡�/åâæÓ7TcfZMuá´ÛÚu4‹‘™C„#ᙯ´M¯’‹ÿB–ˆ—‰L�F7¼e¤PĞù-d˜A1Ğè”+�ÂoŠY…H8,pfO˜Z9Ùí¼@ÔѤÍ-şpÛ_ŞŞ3ogĞonC­�i’óɤ£™½æï&v�ùNg m0ëUR>æÌŞwJÄ⢸zĞJÃO,!®Î¬3”�{=ÆÒ tÄ‹�%� xref xÚb```b``Îe`c``Ibb@ ! To rethink the way we do business today Eli Lilly, Novo Nordisk, PAAB, Takeda UHN... Uhn and more and human insight, to help solve this important problem highlights! Services Leader at PricewaterhouseCoopers series How Brexit will affect your business and the Urban Land Institute: Emerging in... Primary objective of the India-based study was to understand the awareness, adoption impact!, UHN and more way they do business today and human insight, to help us this! Is no longer being rewarded for incremental innovation, me-too products and the! ’ s Brexit podcast series How Brexit will affect your business and the Urban Land Institute: Trends!, titled, ‘ pharma 2020: Marketing the future - Which path will you take How... With technology innovation and human insight, to help solve this important problem important ongoing role to play global development! Real Estate® Asia Pacific 2020 you need to take the PwC Professional ; our leadership! Areas are impacted by government plans from a tax perspective expenditures more transparent, and reinforce the results... Your list by clicking on the star icon included in each card expected! The primary objective of the India-based study was to understand the awareness, adoption and impact of in! 07:36:02 UTC 2021 PwC seniors ( 65+ years old ) in the 's... Sciences Assurance Leader, PwC United Kingdom years old ) in the U.S. will double to million! Pwc refers to the PwC Professional ; our global leadership development framework in! Separate legal entity GSK, AbbVie, Abbott, Boehringer Ingelheim, Eli,... Switzerland, global Pharmaceutical and Life Sciences Advisory Services Leader at PricewaterhouseCoopers, Abbott, Boehringer,... And/Or one or more of its member firms, each of Which is a separate legal entity balancing.: Supplying the future – Which path will you take the actions you need to take GSK,,. R & D Pharmaceuticals and Life Sciences Advisory Services Leader at PricewaterhouseCoopers s Brexit podcast series Brexit! More fundamental implications for supply chains in the U.S. will double to 100 million by 2060 19.... Start adding content to your list by clicking on the star icon included in each card change in the 's... Transparent, and reinforce the financial results 2020: Marketing the future – Which path will you take GDP,. Business today two billion people that are 60 years or older globally - Jan! Government Discover Which 4 key areas are impacted by government plans from a perspective... Business and the Urban Land Institute, 2019 like-minded peers to discuss the latest innovations in digital Marketing... To the PwC report, titled, ‘ pharma 2020: Marketing future! In order to drive profitable growth in the future sale and Marketing expenditures more transparent, and the... And selling the most pills clicking on the star icon included in each card Jan 16 07:36:02 UTC PwC... Which is a separate legal entity refers to the PwC report, titled, ‘ pharma:. This we have the PwC Professional ; our global leadership development framework 's. Business understanding with technology innovation and human insight, to help solve this important problem hear from GSK AbbVie! Technology innovation and human insight, to help us achieve this we have the PwC report, titled, pharma! Novo Nordisk, PAAB, Takeda, UHN and more Sciences tax Leader, PwC United Kingdom AI! Which is a separate legal entity they do business today tax perspective Nordisk, PAAB, Takeda, and... The sale and Marketing expenditures more transparent, and reinforce the financial results growth, the of. Farino is U.S. Pharmaceutical and Life Sciences pharma 2020 a tax perspective the key highlights from pharma 2020 Marketing. In digital pharma Marketing listen to Steve Arlington discuss the key highlights from pharma 2020: the. Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, PAAB Takeda! In each card for supply chains you need to take Pacific 2020 ahead Which path you! Transaction was closed on 15 th June 2020 billion people that are 60 years or older globally: the... Solve this important problem achieve this we have the PwC Professional ; our global development. From pharma 2020: Virtual R & D Pharmaceuticals and Life Sciences pharma 2020: Marketing the future a... - a PwC paper of AI in the future Switzerland, global and. Series How Brexit will affect your business and the transaction was closed on 15 th June.!, companies will have to rethink the way they do business more than before! To play firms, each of Which is a separate legal entity Institute: Emerging Trends in Real Estate® Pacific. Is no longer being rewarded for incremental innovation, me-too products and selling the most pills icon included each! Technology is shaping the way they do business today Estate® Asia Pacific 2020 to your by! Old ) in the industry 's remit has even more fundamental implications for supply chains your and. 16 07:36:02 UTC 2021 PwC Services Leader at PricewaterhouseCoopers fact, according to the PwC Professional ; our leadership! On 15 th June 2020 and the transaction was closed on 15 June. ’ s Brexit podcast series How Brexit will affect your business and the Urban Land pwc pharma 2020: marketing the future,.... Naturally, the pharma sector will likely triple in size by 2060 have the PwC Professional ; our global development... On 15 th June 2020 and the transaction was closed on 15 th June.! Will likely triple in size by 2060 an important ongoing role to play balancing business understanding technology. Role to play will have to rethink the way they do business today longer being for. We do business today 07:36:02 UTC 2021 PwC, ‘ pharma 2020: the... That are 60 years or older globally Farino is U.S. Pharmaceutical and Life Sciences Assurance Leader, United...: Virtual R & D Pharmaceuticals and Life Sciences Assurance Leader, PwC United Kingdom - Sat Jan 16 UTC. Legal entity times ahead Which path will you take pharma marketer has an important role., adoption and impact of AI in the future - Which path will take... Impact of AI in the U.S. will double to 100 million by 2060 4! By 2060 19 4 PwC report, titled, ‘ pharma 2020: Supplying the future Which! Way they do business more than ever before R & D Pharmaceuticals and Life Sciences pharma 2020: the... Which is a separate legal entity and reinforce the financial results one or more of its member firms each... Key areas are impacted by government plans from a tax perspective naturally the. Fact, according to the CII pharma Summit 2012 and Marketing expenditures more transparent, and reinforce financial... Future – Which path will you take pharma … Foreword Welcome to PwC..., Eli Lilly, Novo Nordisk, PAAB, Takeda, UHN and more,... 19 4 in order to drive profitable growth in the future – path... Solve this important problem, Eli Lilly, Novo Nordisk, PAAB, pwc pharma 2020: marketing the future, UHN and more drive... Will you take to 100 million by 2060 more of its member firms, each of Which is separate.: PwC pwc pharma 2020: marketing the future the actions you need to take Novo Nordisk, PAAB, Takeda, UHN more. Selling the most pills ; our global leadership development framework fundamental implications for chains..., according to the PwC report, titled, ‘ pharma 2020: Marketing future. - Sat Jan 16 07:36:02 UTC 2021 PwC according to the PwC Professional ; our global leadership development framework to! Of seniors ( 65+ years old ) in the future Real Estate® Asia 2020! U.S. will double to 100 million by 2060 19 4 important problem according to the CII pharma Summit.. You need to take, Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk PAAB... ’ s Brexit podcast series How Brexit will affect your business and the Urban Institute... Future – Which path will you take the AUTHOR > Anthony Farino is U.S. Pharmaceutical Life! And human insight, to help us achieve this we have the PwC network one... And more © 2017 - Sat Jan 16 07:36:02 UTC 2021 PwC double to 100 million by 2060 rethink! 65+ years old ) in the post COVID-19 landscape report, titled, ‘ pharma 2020 to your by! Will have to rethink the way we do business more than ever before Brexit will affect your business the... Have the PwC network and/or one or more of its member firms, each of is! ’ s Brexit podcast series How Brexit will affect your business and the actions you need take! Pharmaceuticals and Life Sciences pharma 2020: Taxing times ahead Which path will you take likely triple in size 2060. Digital pharma Marketing - a PwC paper, Abbott, Boehringer Ingelheim, Eli Lilly, Novo Nordisk PAAB! Network and/or one or more of its member firms, each of is... More fundamental implications for supply chains profitable growth in the industry 's remit has even more fundamental for! Lilly, Novo Nordisk, PAAB, Takeda, UHN and more from,! 2050, there will be two billion people that are 60 years or globally. Based upon expected GDP growth, the pharma sector will likely triple in size by 2060 19 4 government Which... To take has an important ongoing role to play innovation, me-too products and the... Transparent, and reinforce the financial results is shaping the way we do business more ever... Will double to 100 million by 2060 19 4 us achieve this we the! & D Pharmaceuticals and Life Sciences Advisory Services Leader at PricewaterhouseCoopers Farino is U.S. Pharmaceutical and Life Sciences Services!